MEDICAL NEWS
Mammogram Decision Hinges on Patient-Doc Talk, Ob-Gyn Group Says
5:00 PM EST.
Updated guidelines say average-risk women can start screening at age 40
By Kathleen DohenyHealthDay Reporter Read article
- Secondhand Smoke Still Plagues Some Cancer Survivors
- Big Gap in Cancer Deaths Between Rich, Poor Countries
- Many Doctors Silent on Cost of Cancer Care
- When Is Risk Highest for Women With Breast Cancer Gene Mutations?
JOURNAL UPDATE
ACOG: Shared Decision-Making Key to Breast Cancer Screening
12:00 PM EST. Critically important for patient's value, preferences be factored into process, ACOG leader says- Family History Questionnaire Ups Genetic Counseling for CRC
- Drug, Herb Interactions Frequent for Cancer Patients
- 1991-2014 Saw Minimal Change in Health Spending Per State
MONTHLY JOURNAL SUMMARY
May 2017 Briefing - Hematology & Oncology
June 01, 2017. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
Bert Vogelstein explains cancer and the unavoidable replicative mutations
Bert Vogelstein, MD.
Investigators at Johns Hopkins University in Baltimore used complex mathematical modeling to track mutations driving abnormal cell growth for 32 types of cancer. From their calculations, the researchers believe that the bulk of cancers are caused by random DNA copying errors (replicative mutations).…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
BRCA mutation testing
By Tamer M. Fouad, M.D.The BRCA gene test is used to identify mutations in either one of the two breast cancer susceptibility genes, BRCA1 and BRCA2. Women who have inherited…
DISCUSSION
RE: Aspirin Use as Treatment in Colorectal Cancer: Teaching an Old Dog New Tricks
By Jeffrey A. Gordon, M.D.Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
ANNOUNCEMENTS
Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.
